Quincy Bioscience
TINA.org investigated Quincy Bioscience’s marketing of its brain supplement Prevagen, and was involved as amicus curiae in two separate lawsuits filed against the company. To read more about those efforts, click here.
Brands
Featured
Prevagen Memory Study Falls Short
TINA.org, AARP and others file legal brief urging court to reverse dismissal of Prevagen case.
The Latest
Which of these Products are April Fools?
Take this quiz to test your buyer beware prowess.
Ad Watchdog Calls Out Broadcast Networks for Airing Deceptive Ads
TINA.org Urges Better Screening MADISON, CONN., January 19, 2016 – Consumer advocacy organization, truthinadvertising.org (TINA.org), has put major broadcast networks on notice regarding deceptive advertising. The ad watchdog alerted ABC,…
TINA.org Alerts Major TV Networks to Deceptive Prevagen Ads
TINA.org also calls on the BBB to re-evaluate company’s A+ rating.
Deceptive Ads 2015
FTC Complaint Filed Against Maker of Memory Supplement
Ad Watchdog Issues Warning to Consumers MADISON, CONN. September 21, 2015 — With an aging baby-boomer population and an estimated 10 million Americans predicted to develop some form of brain…
TINA.org to FTC: Prevagen is Making Unsupported Memory Claims
Investigation finds no competent evidence to support memory improvement claims and FTC files a lawsuit.
FTC: Memory Pill Marketers ‘Couldn’t Back Up Claims’
For that reason, the marketers behind the brain supplement Procera AVH will pay $1.4 million.
Prevagen
Brain supplement faces lawsuit over improved brain function claims.
Class-Action Tracker
Prevagen
False advertising class-action lawsuits filed against Quincy Bioscience regarding its marketing of Prevagen